Concerted Actions of the Catechol O-methyltransferase and the Cytosolic Sulfotransferase SULT1A3 in the Metabolism of Catecholic Drugs

Overview

Journal Biochem Pharmacol

Specialties Biochemistry
Pharmacology

Date 2012 Aug 25

PMID 22917559

Citations 7

Authors

Katsuhisa Kurogi

Adnan Alazizi

Ming-Yih Liu

Yoichi Sakakibara

Masahito Suiko

Takuya Sugahara

Ming-Cheh Liu

Affiliations

Soon will be listed here.

Abstract

Catecholic drugs had been reported to be metabolized through conjugation reactions, particularly methylation and sulfation. Whether and how these two Phase II conjugation reactions may occur in a concerted manner, however, remained unclear. The current study was designed to investigate the methylation and/or sulfation of five catecholic drugs. Analysis of the spent media of HepG2 cells metabolically labeled with [(35)S]sulfate in the presence of individual catecholic drugs revealed the presence of two [(35)S]sulfated metabolites for dopamine, epinephrine, isoproterenol, and isoetharine, but only one [(35)S]sulfated metabolite for apomorphine. Further analyses using tropolone, a catechol O-methyltransferase (COMT) inhibitor, indicated that one of the two [(35)S]sulfated metabolites of dopamine, epinephrine, isoproterenol, and isoetharine was a doubly conjugated (methylated and sulfated) product, since its level decreased proportionately with increasing concentrations of tropolone added to the labeling media. Moreover, while the inhibition of methylation resulted in a decrease of the total amount of [(35)S]sulfated metabolites, sulfation appeared to be capable of compensating the suppressed methylation in the metabolism of these four catecholic drugs. A two-stage enzymatic assay showed the sequential methylation and sulfation of dopamine, epinephrine, isoproterenol, and isoetharine mediated by, respectively, the COMT and the cytosolic sulfotransferase SULT1A3. Collectively, the results from the present study implied the concerted actions of the COMT and SULT1A3 in the metabolism of catecholic drugs.

Citing Articles

Distribution and toxicity of dihydroxybenzenes in drinking water sources in Nigeria.

Otitoju O, Alfred M, Olorunnisola C, Aderinola F, Ogunlaja O, Olukanni O RSC Adv. 2024; 14(2):982-994.

PMID: 38174237 PMC: 10759166. DOI: 10.1039/d3ra04877b.

Siderophore conjugates to combat antibiotic-resistant bacteria.

Rayner B, Verderosa A, Ferro V, Blaskovich M RSC Med Chem. 2023; 14(5):800-822.

PMID: 37252105 PMC: 10211321. DOI: 10.1039/d2md00465h.

Pharmacophore-based virtual screening of catechol-o-methyltransferase (COMT) inhibitors to combat Alzheimer's disease.

Patel C, Georrge J, Modi K, Narechania M, Patel D, Gonzalez F J Biomol Struct Dyn. 2017; 36(15):3938-3957.

PMID: 29281938 PMC: 6371058. DOI: 10.1080/07391102.2017.1404931.

Updated perspectives on the cytosolic sulfotransferases (SULTs) and SULT-mediated sulfation.

Suiko M, Kurogi K, Hashiguchi T, Sakakibara Y, Liu M Biosci Biotechnol Biochem. 2016; 81(1):63-72.

PMID: 27649811 PMC: 8248684. DOI: 10.1080/09168451.2016.1222266.

Methylation and its role in the disposition of tanshinol, a cardiovascular carboxylic catechol from Salvia miltiorrhiza roots (Danshen).

Tian D, Jia W, Liu X, Wang D, Liu J, Dong J Acta Pharmacol Sin. 2015; 36(5):627-43.

PMID: 25891082 PMC: 4422947. DOI: 10.1038/aps.2015.20.

References

McFadden Jr E . Beta 2 receptor agonist: metabolism and pharmacology. J Allergy Clin Immunol. 1981; 68(2):91-7. DOI: 10.1016/0091-6749(81)90164-0. View

van der Geest R, Kruger P, Gubbens-Stibbe J, van Laar T, Bodde H, Danhof M . Assay of R-apomorphine, S-apomorphine, apocodeine, isoapocodeine and their glucuronide and sulfate conjugates in plasma and urine of patients with Parkinson's disease. J Chromatogr B Biomed Sci Appl. 1998; 702(1-2):131-41. DOI: 10.1016/s0378-4347(97)00370-8. View

Tenhunen J, Salminen M, Lundstrom K, Kiviluoto T, Savolainen R, Ulmanen I . Genomic organization of the human catechol O-methyltransferase gene and its expression from two distinct promoters. Eur J Biochem. 1994; 223(3):1049-59. DOI: 10.1111/j.1432-1033.1994.tb19083.x. View

Almquist A, Goldenberg I, MILSTEIN S, Chen M, Chen X, Hansen R . Provocation of bradycardia and hypotension by isoproterenol and upright posture in patients with unexplained syncope. N Engl J Med. 1989; 320(6):346-51. DOI: 10.1056/NEJM198902093200603. View

Yasuda S, Yasuda T, Hui Y, Liu M, Suiko M, Sakakibara Y . Concerted action of the cytosolic sulfotransferase, SULT1A3, and catechol-O-methyltransferase in the metabolism of dopamine in SK-N-MC human neuroblastoma cells. Neurosci Res. 2009; 64(3):273-9. DOI: 10.1016/j.neures.2009.03.011. View

Creveling C, Morris N, Shimizu H, Ong H, Daly J . Catechol O-methyltransferase. IV. Factors affecting m- and p-methylation of substituted catechols. Mol Pharmacol. 1972; 8(4):398-409. View

Strott C . Sulfonation and molecular action. Endocr Rev. 2002; 23(5):703-32. DOI: 10.1210/er.2001-0040. View

Adjei A, Weinshilboum R . Catecholestrogen sulfation: possible role in carcinogenesis. Biochem Biophys Res Commun. 2002; 292(2):402-8. DOI: 10.1006/bbrc.2002.6658. View

Klarr J, Faix R, Pryce C, Bhatt-Mehta V . Randomized, blind trial of dopamine versus dobutamine for treatment of hypotension in preterm infants with respiratory distress syndrome. J Pediatr. 1994; 125(1):117-22. DOI: 10.1016/s0022-3476(94)70137-7. View

10.

Zhu B . Catechol-O-Methyltransferase (COMT)-mediated methylation metabolism of endogenous bioactive catechols and modulation by endobiotics and xenobiotics: importance in pathophysiology and pathogenesis. Curr Drug Metab. 2002; 3(3):321-49. DOI: 10.2174/1389200023337586. View

11.

Williams F, Briant R, Dollery C, Davies D . The influence of the route of administration on urinary metabolites of isoetharine. Xenobiotica. 1974; 4(6):345-53. DOI: 10.3109/00498257409052110. View

12.

Mannisto P, Kaakkola S . Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors. Pharmacol Rev. 1999; 51(4):593-628. View

13.

Bai H, Shim J, Yu J, Zhu B . Biochemical and molecular modeling studies of the O-methylation of various endogenous and exogenous catechol substrates catalyzed by recombinant human soluble and membrane-bound catechol-O-methyltransferases. Chem Res Toxicol. 2007; 20(10):1409-25. DOI: 10.1021/tx700174w. View

14.

Missala K, Lal S, Sourkes T . O-methylation of apomorphine and the metabolic prolongation of apomorphine-induced stereotyped behaviour. Eur J Pharmacol. 1973; 22(1):54-8. DOI: 10.1016/0014-2999(73)90183-0. View

15.

Pai T, Sugahara T, Suiko M, Sakakibara Y, Xu F, Liu M . Differential xenoestrogen-sulfating activities of the human cytosolic sulfotransferases: molecular cloning, expression, and purification of human SULT2B1a and SULT2B1b sulfotransferases. Biochim Biophys Acta. 2002; 1573(2):165-70. DOI: 10.1016/s0304-4165(02)00416-6. View

16.

Laemmli U . Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970; 227(5259):680-5. DOI: 10.1038/227680a0. View

17.

Coughtrie M . Catecholamine sulfation in health and disease. Adv Pharmacol. 1997; 42:339-42. DOI: 10.1016/s1054-3589(08)60759-0. View

18.

Liu M, LIPMANN F . Decrease of tyrosine-O-sulfate-containing proteins found in rat fibroblasts infected with Rous sarcoma virus or Fujinami sarcoma virus. Proc Natl Acad Sci U S A. 1984; 81(12):3695-8. PMC: 345285. DOI: 10.1073/pnas.81.12.3695. View

19.

LIPMANN F . Biological sulfate activation and transfer. Science. 1958; 128(3324):575-80. DOI: 10.1126/science.128.3324.575. View

20.

Miyano J, Yamamoto S, Hanioka N, Narimatsu S, Ishikawa T, Ogura K . Involvement of SULT1A3 in elevated sulfation of 4-hydroxypropranolol in Hep G2 cells pretreated with beta-naphthoflavone. Biochem Pharmacol. 2005; 69(6):941-50. DOI: 10.1016/j.bcp.2004.12.012. View